For research use only. Not for therapeutic Use.
IMM-H007(Cat No.:I029271)is an investigational small molecule inhibitor that targets the immunoregulatory pathway involving the PD-1/PD-L1 axis. By blocking this immune checkpoint, IMM-H007 aims to enhance the body’s immune response against tumor cells, making it a promising candidate for cancer immunotherapy. It works by preventing the binding of PD-L1 to PD-1 receptors on T cells, thereby boosting T cell activation and increasing the immune system’s ability to recognize and destroy cancer cells. IMM-H007 is being studied in clinical trials for its potential to treat various cancers, including solid tumors and hematologic malignancies.
CAS Number | 1221412-23-2 |
Synonyms | [(2R,3R,4R,5R)-3,4-diacetyloxy-5-[6-(3-hydroxyanilino)purin-9-yl]oxolan-2-yl]methyl acetate |
Molecular Formula | C22H23N5O8 |
Purity | ≥95% |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |